Sino Biopharmaceutical (OTCMKTS:SBMFF – Get Free Report) saw a significant decline in short interest in the month of July. As of July 31st, there was short interest totaling 27,548,732 shares, a decline of 49.2% from the July 15th total of 54,218,169 shares. Approximately 0.1% of the shares of the company are sold short. Based on an average daily trading volume, of 0 shares, the short-interest ratio is presently ∞ days.
Sino Biopharmaceutical Price Performance
SBMFF stock opened at $0.61 on Friday. The business has a 50 day simple moving average of $0.62 and a 200-day simple moving average of $0.72. Sino Biopharmaceutical has a twelve month low of $0.59 and a twelve month high of $1.24.
Sino Biopharmaceutical Company Profile
Sino Biopharmaceutical Limited (OTCMKTS: SBMFF) is a Hong Kong–incorporated investment holding company principally engaged in the pharmaceutical sector. Founded in 2000 and listed on the Hong Kong Stock Exchange in 2006, the company has developed an integrated business model that spans research and development, manufacturing and commercialization of healthcare products. Through its subsidiaries, Sino Biopharmaceutical focuses on enhancing China’s domestic pharmaceutical infrastructure while expanding its footprint across key therapeutic areas.
The company’s product portfolio is organized into three core segments: infusion solutions, small-molecule synthetic pharmaceuticals and innovative biologics.
Featured Stories
- Five stocks we like better than Sino Biopharmaceutical
- Microsoft’s Maia 300 Chip Targets NVIDIA’s AI Dominance
- 3 Unexpected ETFs Crushing the Market This Summer
- Is Best Buy the AI Winner Hiding in the Electronics Aisle?
- Applied Materials Beat Everything but Wall Street’s Expectations for Margins
Receive News & Ratings for Sino Biopharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sino Biopharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.